Skip to main content

Incyte Corp

INCY
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0000879169

In the last 90 days, Incyte Corp insiders filed 0 open-market purchases and 10 sales; 860 institutions reported holding it in 13F filings for Q2 2026, worth $23.0B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Incyte Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
10 filings
4 insiders, $18.2M in total
Insiders trading
4
Net value
−$18.2M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Incyte Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Incyte Corp
NameTitleLast reported holdingLast filingFilings, past year
Gardner David HEVP, Chief Strategy Officer15,904Sep 24, 20262
Cagnoni Pablo JPresident, Global Head of R&D183,200Sep 17, 202613
Basi Ramitpal KEVP, Human Resources10,993Aug 27, 20262
Mayes Patrick AEVP & Chief Scientific Officer61,441Aug 7, 20268
Morrissey Michael JamesEVP, Head of Tech. Operations34,065Jul 27, 20266
Heeson LeeEVP, Head of Incyte Intl38,041Jul 27, 20265
Tray ThomasPrincipal Accounting Officer21,699Jul 20, 20268
Stein Steven HCMO & Head of Late-Stage Dev.30,916Jul 20, 20269
Issa Mohamed KhairieEVP, Head of U.S. Commercial71,797Jul 20, 20264
Hoffman Richard A.EVP & General Counsel16,861Jul 20, 20262
Meury WilliamChief Executive Officer183,129Jul 20, 20263
Baker JulianDirector, 10% Owner28,205,760IndirectJul 2, 20266
Baker FelixDirector, 10% Owner28,205,760IndirectJul 2, 20266
Baker Bros. Advisors LPDirector, 10% Owner28,205,760IndirectJul 2, 20266
Baker Brothers Life Sciences LPDirector, 10% Owner28,205,760IndirectJul 2, 20266
667, L.P.Director, 10% Owner28,205,760IndirectJul 2, 20266
Baker Bros. Advisors (GP) LLCDirector, 10% Owner28,205,760IndirectJul 2, 20266
Clancy Paul JDirector25,635Jul 2, 20266
Harrigan EdmundDirector23,019Jul 2, 20265
Brawley Otis WDirector12,894Jun 10, 20261
Bienaime Jean JacquesDirector24,424Jun 10, 20262
Fouse Jacqualyn ADirector20,968Jun 10, 20261
High Katherine ADirector14,983Jun 10, 20261
Upadhyay SuketuEVP & Chief Financial Officer26,343May 6, 20261
Trotta MatteoEVP, GM, Dermatology US14,882Mar 26, 20262
Hoppenot HerveDirector326,803Dec 10, 20252
Denton Sheila A.EVP & General Counsel26,569Nov 19, 20254
Flannelly Barry PEVP & General Manager US35,149Jul 17, 20250
Iyengar Vijay KEVP, GMAPPS40,540Jul 17, 20250
Swain Paula JEVP, Human Resources106,482Jul 16, 20250
Stamoulis ChristianaEVP & Chief Financial Officer125,759Jul 16, 20250
Schaffert SusanneDirector7,389Jun 12, 20250
Dickinson Jonathan ElliottEVP, General Manager, Europe36,390Sep 16, 20240
Pasquale Maria EEVP & General Counsel69,724Jul 18, 20230
Dhanak DashyantEVP & Chief Scientific Officer58,968Jul 18, 20230
Dixon Wendy LDirector17,768Apr 4, 20220
Trower PaulPrincipal Accounting Officer32,268Jan 21, 20220
Wenqing YaoEVP, Head of Discovery Chem98,575Jul 7, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 17, 2026 (view filing)4:04 PM ETSep 152 daysCagnoni Pablo JPresident, Global Head of R&DSSale−23.2K$120.49−$2.80M−11.2%183.2K after2 lots10b5-1
Aug 20, 2026 (view filing)5:15 PM ETAug 191 dayCagnoni Pablo JPresident, Global Head of R&DSSale−10.8K$125.56−$1.36M−5.6%183.2K after10b5-1
Aug 14, 2026 (view filing)4:01 PM ETAug 122 daysCagnoni Pablo JPresident, Global Head of R&DSSale−10.8K$120.04−$1.30M−5.3%194.0K after10b5-1
Aug 7, 2026 (view filing)4:02 PM ETAug 52 daysCagnoni Pablo JPresident, Global Head of R&DSSale−10.6K$122.69−$1.31M−4.9%204.8K after10b5-1
Aug 7, 2026 (view filing)4:01 PM ETAug 52 daysMayes Patrick AEVP & Chief Scientific OfficerSSale−2.21K$123.99−$273.6K−3.5%61.4K after10b5-1
Aug 4, 2026 (view filing)4:04 PM ETJul 314 daysCagnoni Pablo JPresident, Global Head of R&DSSale−15.9K$119.70−$1.90M−6.9%215.4K after10b5-1
Aug 4, 2026 (view filing)4:04 PM ETJul 31-Aug 34 daysMayes Patrick AEVP & Chief Scientific OfficerSSale−48.0K$119.58−$5.73M−43.8%61.4K after12 lots10b5-1
Jul 20, 2026 (view filing)4:10 PM ETJul 164 daysStein Steven HCMO & Head of Late-Stage Dev.SSale−1.88K$114.73−$215.3K−8.2%21.1K after10b5-1
Jul 20, 2026 (view filing)4:09 PM ETJul 164 daysIssa Mohamed KhairieEVP, Head of U.S. CommercialSSale−1.09K$115.01−$125.7K−1.7%63.9K after10b5-1
Jul 16, 2026 (view filing)4:07 PM ETJul 151 dayStein Steven HCMO & Head of Late-Stage Dev.SSale−28.2K$113.05−$3.19M−52.0%26.1K after10b5-1
Jun 8, 2026 (view filing)Jun 44 daysTray ThomasPrincipal Accounting OfficerSSale−2.64K$100.00−$263.9K−11.1%21.1K after10b5-1
May 28, 2026 (view filing)May 262 daysTray ThomasPrincipal Accounting OfficerSSale−2.05K$97.35−$199.7K−8.8%21.1K after10b5-1
May 21, 2026 (view filing)May 192 daysClancy Paul JDirectorSSale−15.0K$94.93−$1.42M−38.7%23.7K after10b5-1
Apr 21, 2026 (view filing)Apr 174 daysCagnoni Pablo JPresident, Global Head of R&DSSale−18.7K$96.50−$1.80M−6.6%262.7K after10b5-1
Mar 19, 2026 (view filing)Mar 172 daysCagnoni Pablo JPresident, R&DSSale−18.7K$94.24−$1.76M−7.4%234.8K after10b5-1
Feb 23, 2026 (view filing)Feb 194 daysCagnoni Pablo JPresident, R&DSSale−18.7K$100.91−$1.88M−7.4%234.8K after10b5-1
Jan 8, 2026 (view filing)Jan 71 dayIssa Mohamed KhairieEVP, Head of US OncologySSale−10.9K$109.07−$1.18M−14.1%66.1K after10b5-1
Jan 7, 2026 (view filing)Jan 52 daysStein Steven HEVP & Chief Medical OfficerSSale−15.6K$101.70−$1.59M−31.4%34.2K after10b5-1
Dec 22, 2025 (view filing)Dec 18-194 daysTray ThomasPrincipal Accounting OfficerSSale−3.37K$99.69−$336.4K−12.8%23.0K after2 lots10b5-1
Dec 18, 2025 (view filing)Dec 16-172 daysMorrissey Michael JamesEVP, Head of Tech. OperationsSSale−58.3K$97.29−$5.68M−68.0%27.5K after3 lots10b5-1
Dec 12, 2025 (view filing)Dec 10-112 daysMayes Patrick AEVP & Chief Scientific OfficerSSale−5.81K$95.55−$555.0K−8.8%60.0K after2 lots10b5-1
Dec 3, 2025 (view filing)Dec 1-22 daysStein Steven HEVP & Chief Medical OfficerSSale−22.7K$102.56−$2.32M−26.4%63.1K after2 lots10b5-1
Nov 25, 2025 (view filing)Nov 21-244 daysTray ThomasPrincipal Accounting OfficerSSale−769$102.78−$79.0K−3.2%23.6K after2 lots10b5-1
Nov 19, 2025 (view filing)Nov 172 daysDenton Sheila A.EVP & General CounselSSale−278$104.36−$29.0K−1.0%26.6K after10b5-1
Nov 12, 2025 (view filing)Nov 102 daysHoppenot HerveDirectorSSale−187.5K$105.46−$19.8M−36.3%329.6K after10b5-1
Nov 7, 2025 (view filing)Nov 52 daysStein Steven HEVP & Chief Medical OfficerSSale−5.23K$102.20−$534.8K−4.8%102.9K after10b5-1
Nov 6, 2025 (view filing)Nov 42 daysDenton Sheila A.EVP & General CounselSSale−598$101.36−$60.6K−2.2%26.6K after10b5-1
Nov 5, 2025 (view filing)Nov 32 daysHeeson LeeEVP, Head of Incyte IntlSSale−3.07K$94.02−$289.0K−9.5%29.2K after10b5-1
Oct 17, 2025 (view filing)Oct 152 daysDenton Sheila A.EVP & General CounselSSale−277$85.13−$23.6K−1.0%26.6K after10b5-1
Oct 6, 2025 (view filing)Oct 2-34 daysDenton Sheila A.EVP & General CounselSSale−4.10K$85.85−$352.0K−13.4%26.6K after2 lots10b5-1
Sep 18, 2025 (view filing)Sep 162 daysDenton Sheila A.EVP & General CounselSSale−278$83.15−$23.1K−0.8%33.2K after10b5-1
Sep 4, 2025 (view filing)Sep 22 daysDenton Sheila A.EVP & General CounselSSale−598$84.97−$50.8K−1.8%33.2K after10b5-1
Aug 19, 2025 (view filing)Aug 154 daysDenton Sheila A.EVP & General CounselSSale−277$86.81−$24.0K−0.8%33.2K after10b5-1
Aug 6, 2025 (view filing)Aug 42 daysDenton Sheila A.EVP & General CounselSSale−598$75.77−$45.3K−1.8%33.2K after10b5-1
Jul 23, 2025 (view filing)Jul 212 daysStein Steven HEVP & Chief Medical OfficerSSale−3.71K$67.94−$251.8K−3.5%102.9K after10b5-1
Jul 17, 2025 (view filing)Jul 161 dayFlannelly Barry PEVP & General Manager USSSale−1.34K$68.36−$91.6K−3.7%35.1K after10b5-1
Jul 17, 2025 (view filing)Jul 161 dayIyengar Vijay KEVP, GMAPPSSSale−983$68.36−$67.2K−2.4%40.5K after10b5-1
Jul 17, 2025 (view filing)Jul 15-162 daysDenton Sheila A.EVP & General CounselSSale−4.12K$69.57−$286.3K−11.0%33.2K after2 lots10b5-1
Jul 16, 2025 (view filing)Jul 142 daysStein Steven HEVP & Chief Medical OfficerSSale−15.0K$68.47−$1.02M−13.3%97.5K after10b5-1
Jul 16, 2025 (view filing)Jul 151 dayIyengar Vijay KEVP, GMAPPSSSale−1.18K$69.86−$82.2K−3.2%35.9K after10b5-1
Jul 16, 2025 (view filing)Jul 151 dayFlannelly Barry PEVP & General Manager USSSale−1.19K$69.86−$83.3K−3.1%37.6K after10b5-1
Jul 7, 2025 (view filing)Jul 34 daysFlannelly Barry PEVP & General Manager USSSale−10.9K$68.15−$743.0K−21.5%39.7K after10b5-1
Jul 7, 2025 (view filing)Jul 25 daysDenton Sheila A.EVP & General CounselSSale−599$68.61−$41.1K−2.2%26.5K after10b5-1
Jul 7, 2025 (view filing)Jul 34 daysIyengar Vijay KEVP, GMAPPSSSale−8.62K$68.15−$587.3K−18.6%37.7K after2 lots10b5-1
Jun 5, 2025 (view filing)Jun 32 daysDenton Sheila A.EVP & General CounselSSale−1.79K$68.00−$122.1K−6.3%26.5K after10b5-1
Jun 3, 2025 (view filing)May 30-Jun 24 daysTray ThomasPrincipal Accounting OfficerSSale−1.61K$65.38−$105.5K−6.8%22.0K after2 lots10b5-1
Mar 18, 2025 (view filing)Mar 144 daysFlannelly Barry PEVP & General Manager USSSale−19.8K$67.69−$1.34M−37.1%33.6K after3 lots10b5-1
Mar 6, 2025 (view filing)Mar 42 daysDenton Sheila A.EVP & General CounselSSale−599$69.99−$41.9K−2.3%25.8K after10b5-1
Feb 28, 2025 (view filing)Feb 262 daysDenton Sheila A.EVP & General CounselSSale−14.1K$74.07−$1.04M−35.2%25.8K after2 lots10b5-1
Jan 22, 2025 (view filing)Jan 211 dayStein Steven HEVP & Chief Medical OfficerSSale−12.4K$72.69−$897.9K−15.6%67.0K after10b5-1